文献速递前列腺癌

局限性前列腺癌患者来源细胞系的表征

Characterisation of cell lines derived from prostate cancer patients with localised disease.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2023-06-01

研究从前列腺癌根治术的4例局限性前列腺癌患者获取原发灶及癌旁组织,用HPV16 E6和E7永生化上皮细胞建立单克隆细胞系,并分析染色体倍体、STR图谱、形态、集落形成、增殖、雄激素受体表达与反应性及RNA-seq。成功建立2株良性细胞系(AQ0420和AQ0396)和2株肿瘤组织来源癌细胞系(AQ0411和AQ0415),均呈上皮形态、增殖缓慢至中等,未形成锚定非依赖集落,无雄激素受体反应性,RNA-seq证实前列腺谱系且基因表达谱与转移性细胞系PC-3和LNCaP不同。

要点

  • 从4例局限性前列腺癌患者建立2株良性(AQ0420、AQ0396)和2株肿瘤来源(AQ0411、AQ0415)细胞系。
  • 四株细胞系均呈上皮形态、增殖缓慢至中等,未形成锚定非依赖集落,无雄激素受体反应性。
  • RNA-seq证实四株细胞系为前列腺谱系,基因表达谱与转移性细胞系PC-3和LNCaP不同。

核心结论

  • 对这些细胞系的综合表征可能提供新的体外工具,有望弥合良性、早期和转移性疾病之间现有的知识差距。

研究设计与样本

  • 研究获取4例接受根治性前列腺切除术的局限性前列腺癌患者的原发灶及癌旁非癌组织,用HPV16 E6和E7永生化上皮细胞外生长物以建立单克隆细胞系。
  • 对建立的细胞系进行染色体倍体成像和STR图谱测定,评估细胞形态、集落形成和增殖特征。
  • 用免疫荧光分析雄激素受体表达,用RT-qPCR分析雄激素受体对雄激素处理的反应性,并做RNA-seq鉴定前列腺谱系标志物及前列腺癌肿瘤发生相关基因表达。

主要发现

  • 从4例局限性前列腺腺癌患者永生化出2株良性细胞系(AQ0420和AQ0396)和2株肿瘤组织来源癌细胞系(AQ0411和AQ0415)。
  • 细胞系呈上皮形态,增殖速率缓慢至中等。
  • 所有细胞系均未形成锚定非依赖集落,也未显示雄激素受体反应性。
  • 比较RNA-seq表达分析证实四株细胞系的前列腺谱系,其基因表达谱与转移性前列腺癌细胞系PC-3和LNCaP不同。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate cancer is a broad-spectrum disease, spanning from indolent to a highly aggressive lethal malignancy. Prostate cancer cell lines are essential tools to understanding the basic features of this malignancy, as well as in identifying novel therapeutic strategies. However, most cell lines routinely used in prostate cancer research are derived from metastatic disease and may not fully elucidate the molecular events underlying the early stages of cancer development and progression. Thus, there is a need for new cell lines derived from localised disease to better span the disease spectrum. METHODS: Prostatic tissue from the primary site, and adjacent non-cancerous tissue was obtained from four patients with localised disease undergoing radical prostatectomy. Epithelial cell outgrowths were immortalised with human papillomavirus type 16 (HPV16) E6 and E7 to establish monoclonal cell lines. Chromosomal ploidy was imaged and STR profiles were determined. Cell morphology, colony formation and cell proliferation characteristics were assessed. Androgen receptor (AR) expression and AR-responsiveness to androgen treatment were analysed by immunofluorescence and RT-qPCR, respectively. RNA-seq analysis was performed to identify prostate lineage markers and expression of prostate cancer tumorigenesis-related genes. RESULTS: Two benign cell lines derived from non-cancer cells (AQ0420 and AQ0396) and two tumour tissue derived cancer cell lines (AQ0411 and AQ0415) were immortalised from four patients with localised prostatic adenocarcinoma. The cell lines presented an epithelial morphology and a slow to moderate proliferative rate. None of the cell lines formed anchorage independent colonies or displayed AR-responsiveness. Comparative RNA-seq expression analysis confirmed the prostatic lineage of the four cell lines, with a distinct gene expression profile from that of the metastatic prostate cancer cell lines, PC-3 and LNCaP. CONCLUSIONS: Comprehensive characterization of these cell lines may provide new in vitro tools that could bridge the current knowledge gap between benign, early-stage and metastatic disease.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Moya L, Walpole C, Rae F, et al. Characterisation of cell lines derived from prostate cancer patients with localised disease. Prostate Cancer Prostatic Dis. 2023. PMID: 37264224. doi:10.1038/s41391-023-00679-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。